NASDAQ:SWAV Shockwave Medical - SWAV Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Shockwave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $217.92 +3.68 (+1.72%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$214.57▼$220.0050-Day Range$175.41▼$217.9252-Week Range$113.36▼$320.54Volume307,623 shsAverage Volume489,031 shsMarket Capitalization$7.95 billionP/E Ratio38.23Dividend YieldN/APrice Target$247.40 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Shockwave Medical MarketRank™ ForecastAnalyst RatingModerate Buy2.56 Rating ScoreUpside/Downside13.5% Upside$247.40 Price TargetShort InterestHealthy4.14% of Shares Sold ShortDividend StrengthN/ASustainability-0.55Upright™ Environmental ScoreNews Sentiment0.36Based on 9 Articles This WeekInsider TradingSelling Shares$12.37 M Sold Last QuarterProj. Earnings Growth15.82%From $3.92 to $4.54 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.81 out of 5 starsMedical Sector57th out of 995 stocksSurgical & Medical Instruments Industry5th out of 103 stocks 3.3 Analyst's Opinion Consensus RatingShockwave Medical has received a consensus rating of Buy. The company's average rating score is 2.56, and is based on 6 buy ratings, 2 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $247.40, Shockwave Medical has a forecasted upside of 13.5% from its current price of $217.92.Amount of Analyst CoverageShockwave Medical has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.14% of the outstanding shares of Shockwave Medical have been sold short.Short Interest Ratio / Days to CoverShockwave Medical has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Shockwave Medical has recently increased by 16.15%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldShockwave Medical does not currently pay a dividend.Dividend GrowthShockwave Medical does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreShockwave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Shockwave Medical is -0.55. Previous Next 1.9 News and Social Media Coverage News SentimentShockwave Medical has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Shockwave Medical this week, compared to 5 articles on an average week.Search InterestOnly 16 people have searched for SWAV on MarketBeat in the last 30 days. This is a decrease of -27% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Shockwave Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Shockwave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,366,884.00 in company stock.Percentage Held by InsidersOnly 3.90% of the stock of Shockwave Medical is held by insiders.Percentage Held by Institutions90.56% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Shockwave Medical are expected to grow by 15.82% in the coming year, from $3.92 to $4.54 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shockwave Medical is 38.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 125.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Shockwave Medical is 38.23, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 153.15.Price to Book Value per Share RatioShockwave Medical has a P/B Ratio of 15.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Shockwave Medical (NASDAQ:SWAV) StockShockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.Read More Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SWAV Stock News HeadlinesMarch 27, 2023 | americanbankingnews.comShockwave Medical, Inc. (NASDAQ:SWAV) Receives $247.40 Consensus Price Target from AnalystsMarch 24, 2023 | americanbankingnews.comDan Puckett Sells 1,100 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV) StockMarch 28, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.March 24, 2023 | americanbankingnews.comInsider Selling: Shockwave Medical, Inc. (NASDAQ:SWAV) Director Sells 3,000 Shares of StockMarch 17, 2023 | benzinga.comShockWave Medical Stock (NASDAQ:SWAV), Analyst Ratings, Price Targets, PredictionsMarch 14, 2023 | finance.yahoo.comShockwave Medical Announces U.S. Launch of New Peripheral IVL CatheterMarch 10, 2023 | finance.yahoo.com3 Supercharged Stocks That Still Look UnstoppableMarch 8, 2023 | finance.yahoo.comTop Healthcare Stocks for March 2023March 28, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.March 2, 2023 | finance.yahoo.comHere’s Why ShockWave Medical (SWAV) Declined in Q4February 24, 2023 | seekingalpha.comSWAV ShockWave Medical, Inc.February 23, 2023 | finance.yahoo.com3 Exceptional Growth Stocks That Could Shoot 28.3% to 40.6% Higher, According to Wall StreetFebruary 22, 2023 | finance.yahoo.comWall Street Analysts Think Shockwave Medical (SWAV) Could Surge 28.8%: Read This Before Placing a BetFebruary 22, 2023 | finance.yahoo.comA Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and HoldFebruary 18, 2023 | finance.yahoo.comShockWave Medical Full Year 2022 Earnings: EPS Beats ExpectationsFebruary 18, 2023 | finance.yahoo.com2 Beaten-Down Growth Stocks to Buy Now Before They Start Soaring AgainFebruary 17, 2023 | msn.com5 Analysts Have This to Say About ShockWave MedicalFebruary 17, 2023 | finanznachrichten.deShockwave Medical, Inc.: Shockwave Medical Reports Fourth Quarter and Full Year 2022 Financial ResultsFebruary 17, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO), Shockwave Medical (SWAV) and Regeneron (REGN)February 17, 2023 | finance.yahoo.comShockwave Medical Just Tripled Profit Expectations, Delivering 991% GrowthFebruary 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Talaris Therapeutics (TALS) and Shockwave Medical (SWAV)February 16, 2023 | finance.yahoo.comShockwave Medical Reports Fourth Quarter and Full Year 2022 Financial ResultsFebruary 16, 2023 | finance.yahoo.comShockwave Medical (SWAV) Q4 Earnings and Revenues Surpass EstimatesFebruary 15, 2023 | finance.yahoo.comMedical Device Stocks' Q4 Earnings on Feb 16: WST, SWAV & MoreFebruary 10, 2023 | finance.yahoo.comAre Options Traders Betting on a Big Move in ShockWave (SWAV) Stock?February 9, 2023 | finance.yahoo.comShockwave Medical (SWAV) Earnings Expected to Grow: Should You Buy?February 6, 2023 | finance.yahoo.comShockwave Medical (SWAV) Moves to Buy: Rationale Behind the UpgradeSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SWAV Company Calendar Last Earnings2/16/2023Today3/27/2023Next Earnings (Estimated)5/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SWAV CUSIPN/A CIK1642545 Webwww.shockwavemedical.com Phone(877) 775-4846FaxN/AEmployees1,001Year FoundedN/APrice Target and Rating Average Stock Price Forecast$247.40 High Stock Price Forecast$310.00 Low Stock Price Forecast$165.00 Forecasted Upside/Downside+13.5%Consensus RatingModerate Buy Rating Score (0-4)2.56 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$5.70 Trailing P/E Ratio38.23 Forward P/E Ratio55.59 P/E GrowthN/ANet Income$216 million Net Margins44.10% Pretax Margin24.67% Return on Equity59.99% Return on Assets45.20% Debt Debt-to-Equity Ratio0.05 Current Ratio7.25 Quick Ratio6.06 Sales & Book Value Annual Sales$489.73 million Price / Sales16.24 Cash Flow$6.23 per share Price / Cash Flow34.98 Book Value$14.15 per share Price / Book15.40Miscellaneous Outstanding Shares36,490,000Free Float35,072,000Market Cap$7.95 billion OptionableNot Optionable Beta0.97 Key ExecutivesDouglas Evan GodshallPresident, Chief Executive Officer & DirectorMike MaszySenior Vice President-OperationsDaniel PuckettChief Financial Officer & SecretaryBeaux AlexanderVice President-Clinical AffairsW. Patrick StephensVice President-Research & DevelopmentKey CompetitorsInspire Medical SystemsNYSE:INSPStevanato GroupNYSE:STVNNovoCureNASDAQ:NVCRGlobus MedicalNYSE:GMEDPenumbraNYSE:PENView All CompetitorsInsiders & InstitutionsDan PuckettSold 1,100 sharesTotal: $220,814.00 ($200.74/share)Frank T WatkinsSold 3,000 sharesTotal: $602,010.00 ($200.67/share)B. Riley Wealth Advisors Inc.Bought 1,649 shares on 3/15/2023Ownership: 0.005%Victory Capital Management Inc.Sold 27,015 shares on 3/10/2023Ownership: 0.472%Sheets Smith Wealth ManagementBought 2,000 shares on 3/8/2023Ownership: 0.005%View All Insider TransactionsView All Institutional Transactions SWAV Stock - Frequently Asked Questions Should I buy or sell Shockwave Medical stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SWAV shares. View SWAV analyst ratings or view top-rated stocks. What is Shockwave Medical's stock price forecast for 2023? 9 equities research analysts have issued 12 month price targets for Shockwave Medical's shares. Their SWAV share price forecasts range from $165.00 to $310.00. On average, they expect the company's share price to reach $247.40 in the next twelve months. This suggests a possible upside of 13.5% from the stock's current price. View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts. How have SWAV shares performed in 2023? Shockwave Medical's stock was trading at $205.61 at the beginning of 2023. Since then, SWAV stock has increased by 6.0% and is now trading at $217.92. View the best growth stocks for 2023 here. When is Shockwave Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023. View our SWAV earnings forecast. How were Shockwave Medical's earnings last quarter? Shockwave Medical, Inc. (NASDAQ:SWAV) released its quarterly earnings results on Thursday, February, 16th. The company reported $3.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.99 by $2.72. The company earned $144 million during the quarter, compared to the consensus estimate of $143.04 million. Shockwave Medical had a net margin of 44.10% and a trailing twelve-month return on equity of 59.99%. The business's revenue for the quarter was up 71.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.34 EPS. What ETFs hold Shockwave Medical's stock? ETFs with the largest weight of Shockwave Medical (NASDAQ:SWAV) stock in their portfolio include Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Neuberger Berman Disrupters ETF (NBDS), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Invesco S&P MidCap Quality ETF (XMHQ), SPDR S&P Health Care Equipment ETF (XHE), First Trust US Equity Opportunities ETF (FPX), Goldman Sachs Future Health Care Equity ETF (GDOC) and SoFi Next 500 ETF (SFYX). What guidance has Shockwave Medical issued on next quarter's earnings? Shockwave Medical issued an update on its FY 2023 earnings guidance on Wednesday, March, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $660.00 million-$680.00 million, compared to the consensus revenue estimate of $658.58 million. What is Doug Godshall's approval rating as Shockwave Medical's CEO? 8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees. What other stocks do shareholders of Shockwave Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA). When did Shockwave Medical IPO? (SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. What is Shockwave Medical's stock symbol? Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV." Who are Shockwave Medical's major shareholders? Shockwave Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (2.80%), JPMorgan Chase & Co. (2.23%), Macquarie Group Ltd. (2.09%), Gilder Gagnon Howe & Co. LLC (1.95%), Geode Capital Management LLC (1.86%) and Artisan Partners Limited Partnership (1.85%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sofinnova Capital Vii Fcpr and Trinh Phung. View institutional ownership trends. How do I buy shares of Shockwave Medical? Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Shockwave Medical's stock price today? One share of SWAV stock can currently be purchased for approximately $217.92. How much money does Shockwave Medical make? Shockwave Medical (NASDAQ:SWAV) has a market capitalization of $7.95 billion and generates $489.73 million in revenue each year. The company earns $216 million in net income (profit) each year or $5.70 on an earnings per share basis. How many employees does Shockwave Medical have? The company employs 1,001 workers across the globe. How can I contact Shockwave Medical? Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (877) 775-4846 or via email at investors@shockwavemedical.com. This page (NASDAQ:SWAV) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.